Two Sigma Advisers’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-69
Closed -$30K 2672
2021
Q2
$30K Sell
69
-44
-39% -$22K ﹤0.01% 2401
2021
Q1
$64K Sell
113
-52
-32% -$37.5K ﹤0.01% 2483
2020
Q4
$94K Buy
+165
New +$81.9K ﹤0.01% 2276
2020
Q3
Sell
-132
Closed -$43K 2631
2020
Q2
$43K Sell
132
-71
-35% -$16.2K ﹤0.01% 2434
2020
Q1
$34K Sell
203
-16
-7% -$2.51K ﹤0.01% 2395
2019
Q4
$34K Hold
219
﹤0.01% 2302
2019
Q3
$40K Hold
219
﹤0.01% 2163
2019
Q2
$54K Hold
219
﹤0.01% 2251
2019
Q1
$94K Sell
219
-8
-4% -$3.3K ﹤0.01% 2197
2018
Q4
$78K Hold
227
﹤0.01% 2241
2018
Q3
$136K Sell
227
-11
-5% -$7.17K ﹤0.01% 2132
2018
Q2
$179K Hold
238
﹤0.01% 2218
2018
Q1
$184K Sell
238
-38
-14% -$31.1K ﹤0.01% 2162
2017
Q4
$212K Sell
276
-60
-18% -$46.4K ﹤0.01% 2072
2017
Q3
$283K Sell
336
-32
-9% -$26.8K ﹤0.01% 1948
2017
Q2
$331K Sell
368
-169
-31% -$144K ﹤0.01% 1949
2017
Q1
$480K Sell
537
-251
-32% -$235K ﹤0.01% 1914
2016
Q4
$818K Buy
788
+523
+197% +$540K ﹤0.01% 1650
2016
Q3
$525K Sell
265
-32
-11% -$59.8K ﹤0.01% 1664
2016
Q2
$506K Sell
297
-179
-38% -$303K ﹤0.01% 1513
2016
Q1
$833K Sell
476
-77
-14% -$123K ﹤0.01% 1214
2015
Q4
$976K Buy
553
+229
+71% +$405K 0.01% 1030
2015
Q3
$576K Sell
324
-4
-1% -$9.65K ﹤0.01% 1243
2015
Q2
$889K Buy
328
+172
+110% +$447K 0.01% 1171
2015
Q1
$450K Sell
156
-41
-21% -$114K ﹤0.01% 1399
2014
Q4
$517K Buy
+197
New +$509K ﹤0.01% 1603

Other funds holding TRIB

Two Sigma Advisers's TRIB Position: Q3 2021 in Review

Two Sigma Advisers sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 69 shares — an estimated $30K sold.

Two Sigma Advisers first reported a position in TRIB in Q4 2014 and held it in 26 quarters. The position peaked at $976K in Q4 2015. 21 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Two Sigma Advisers reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 69 Trinity Biotech shares in Q3 2021, an estimated $30K.
  • Two Sigma Advisers first reported a position in Trinity Biotech in Q4 2014 and held it in 26 quarters.
  • Two Sigma Advisers's Trinity Biotech position peaked at $976K in Q4 2015.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.